Market News & Trends
SGS Life Science Services Announces New Facility
SGS Life Science Services recently announced further investment in the French market, with a new facility in Villeneuve la Garenne. The new location, which will…
Drug Delivery Institute to Collaborate With Lung Cancer Alliance
The Catalent Applied Drug Delivery Institute recently announced it is to collaborate with the Lung Cancer Alliance on patient research in early October. The collaboration…
Ultra-Rapid-Acting Insulin Formulations Will Revolutionize Type 1 Diabetes Treatment Market by 2019
LONDON, UK (GlobalData), 7 October 2014 - Ultra-rapid formulations of the currently marketed rapid-acting insulin analogs have the clear potential to radically change the insulin…
Unilife Signs 15-Year Commercial Supply Agreement for Wearable Injectors With Sanofi
York, PA. – October 6, 2014 - Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer and supplier of injectable drug delivery systems, announced…
Merck KgaA to Acquire Sigma-Aldrich for $17 Billion
Merck KgaA, a public company based in Darmstadt, Germany, announced it will acquire St.Louis, Mo. based Sigma-Aldrich for $17 billion. This is the largest acquisition…
Global Market for Nanoparticles Instrumentation to Reach $7.8 Billion
The nanoparticle analysis market presents an increasingly significant part of the overall pharmaceutical product analysis market worldwide. In the past two decades, the science of…
Acorda Therapeutics to Acquire Civitas Therapeutics
Acorda Therapeutics, Inc. recently announced it entered into an agreement to acquire Civitas Therapeutics, a privately held biopharmaceutical company, for $525 million in cash. Acorda…
Cingulate Therapeutics & Catalent Sign Exclusive ADHD Agreement
Catalent Pharma Solutions recently announced it had reached an exclusive development and licensing agreement with privately held biopharmaceutical company, Cingulate Therapeutics (CTx), to support the…
Access Pharmaceuticals Announces Global Plasma Therapeutics License
Access Pharmaceuticals has signed an exclusive global license agreement with Plasma Technologies LLC for the development and commercialization of its proprietary plasma fractionation process. Concurrently,…
Abcam & Children’s Cancer Institute Enter Exclusive Agreement
Children’s Cancer Institute and Abcam plc recently announced they have entered into an exclusive licence, supply and distribution agreement for multidrug resistance protein 4 (MRP4/ABCC4)…
SGS Announces Completion of New Lab in CA
SGS Life Science Services recently announced the completion of its fifth North American Life Science Services laboratory, in Carson, California. The new, 8,000-sq-ft GMP/GLP facility…
Daiichi Sankyo to Acquire Ambit Biosciences
Daiichi Sankyo Company, Ltd. and Ambit Biosciences jointly announced they have entered into a definitive merger agreement under which Daiichi Sankyo will acquire all of…
Innovation-by-Outsourcing: Impact on Solubilization Services
By: Marshall Crew, PhD, President & CEO, Agere Pharmaceuticals, Inc. In 2008, research utilizing data from the Business Dynamics Statistics of the US Census…
Global Market for Cancer Profiling Technologies to Reach Nearly $54.8 Billion
The global healthcare industry is seeing new developments, improved point-of-care diagnostics, cost-effective treatment modalities, and advances in personalized medicine, which not only offer efficient early…
Implementing Innovations in Injectable Drug Delivery With the User & Pharmaceutical Manufacturer in Mind
By: John A. Merhige, Chief Commercial Officer, and Dan Thayer, Technology Director, Credence MedSystems, Inc. The Current Climate Change is hard. This is true in…
Medimetrics Expands Medical Device Portfolio
Medtech innovator Medimetrics continues its expansion into the global medical devices sector with official recognition of its full design and product development capabilities and the…
Foster Delivery Science to Build New Facility; Supports Increased Demand
Foster Delivery Science has recently broken ground on a new facility to support increased demand for manufacturing drug delivery and implant polymer blends. The facility…
Cubist Announces Continued Global Expansion Opens International Headquarters
With resistant bacterial infections resulting in an estimated 25,000 deaths in the European Union and 23,000 deaths in the United States annually, the issues of…
Boehringer Ingelheim & CureVac Announce Major Development Collaboration
Boehringer Ingelheim and CureVac recently announced an exclusive global license and development collaboration. The new collaboration focuses on CureVac’s CV9202, a novel investigational therapeutic mRNA…
TapImmune Releases Positive Interim Data for Ovarian & Breast Cancer
TapImmune Inc. is extremely pleased to report that analysis of the interim data from the first 13 patients in a Phase I clinical trial show…
